| 发明名称 |
ARIMOCLOMOL FORMULATION |
| 摘要 |
The present invention relates to a pharmaceutical formulation which provides for extended release of an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof. |
| 申请公布号 |
WO2016041561(A1) |
申请公布日期 |
2016.03.24 |
| 申请号 |
WO2015DK50275 |
申请日期 |
2015.09.15 |
| 申请人 |
ORPHAZYME APS |
发明人 |
HINSBY, ANDERS MØRKEBERG;JENSEN, THOMAS KIRKEGAARD;BOLWIG, GERT MADS;CAMOZZI, CARLOS ROBERTO |
| 分类号 |
A61K9/16;A61K9/50;A61K31/4545 |
主分类号 |
A61K9/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
